When Kiran Mazumdar-Shaw proposed starting Biocon, investors doubted her ability as a woman in a male-dominated biotech field. Early projects struggled for funding, and her ideas were dismissed repeatedly. She persisted, focusing on affordable healthcare and building a small lab in Bangalore. The turning point came when Biocon developed pioneering insulin therapies, gaining global recognition. Her story demonstrates that courage, scientific rigor, and determination can convert skepticism and failure into groundbreaking impact.
